UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Feasibility of and barriers to thalassemia screening in migrant populations: a cross-sectional study of Myanmar and Cambodian migrants in Thailand

BMC public health, 2021-06, Vol.21 (1), p.1-1177, Article 1177

2021

Volltextzugriff (PDF)

Identification of optimal thalassemia screening strategies for migrant populations in Thailand using a qualitative approach

BMC public health, 2021-10, Vol.21 (1), p.1-1796, Article 1796

2021

Volltextzugriff (PDF)

Fatty acid nitroalkenes – Multi-target agents for the treatment of sickle cell disease

Redox biology, 2023-12, Vol.68, p.102941, Article 102941

2023

Volltextzugriff (PDF)

Release of hepatic xanthine oxidase (XO) to the circulation is protective in intravascular hemolytic crisis

Redox biology, 2023-06, Vol.62, p.102636-102636, Article 102636

2023

Volltextzugriff (PDF)

Pyruvate kinase activators: targeting red cell metabolism in sickle cell disease

Hematology, 2023-12, Vol.2023 (1), p.107-113

2023

Volltextzugriff (PDF)

Diagnostic Test Accuracy of Lung Ultrasound for Acute Chest Syndrome in Sickle Cell Disease: A Systematic Review and Meta-analysis

Chest, 2023-06, Vol.163 (6), p.1506

2023

Volltextzugriff (PDF)

A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease

Blood, 2022-11, Vol.140 (19), p.2053-2062

2022

Volltextzugriff (PDF)

Whole genome sequence-based haplotypes reveal a single origin of the 1393 bp HBB deletion

Journal of medical genetics, 2020-08, Vol.57 (8), p.567-570

2020

Volltextzugriff (PDF)

Paper-based microchip electrophoresis for point-of-care hemoglobin testing

Analyst (London), 2020-04, Vol.145 (7), p.2525-2542

2020

Volltextzugriff (PDF)

Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease

American journal of hematology, 2018-12, Vol.93 (12), p.1451-1460

2018

Volltextzugriff (PDF)

The origin of sickle cell disease in Thailand

International journal of laboratory hematology, 2019-02, Vol.41 (1), p.e13-e16

2019

Volltextzugriff (PDF)

Methaemoglobinaemia and haemolysis following pegloticase infusion for refractory gout in a patient with a falsely negative glucose-6-phosphate dehydrogenase deficiency result

Rheumatology (Oxford, England), 2014-12, Vol.53 (12), p.2310-2311

2014

Volltextzugriff (PDF)

G6PD Deficiency in an HIV Clinic Setting in the Dominican Republic

The American journal of tropical medicine and hygiene, 2015-10, Vol.93 (4), p.722-729

2015

Volltextzugriff (PDF)

Diagnostic Test Accuracy of Lung Ultrasound for Acute Chest Syndrome in Sickle Cell Disease

Chest, 2023-06, Vol.163 (6), p.1506-1518

2023

Volltextzugriff (PDF)

Inhibition of Hypoxia Inducible Factor Prolyl Hydroxylase By FG-4592 (Roxadustat) Increases Erythropoietic Stimulation in a Mouse Model of Sickle Cell Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.5391-5392

2022

Volltextzugriff (PDF)

Feasibility of Near-Infrared Spectroscopy for Monitoring Hemodynamic Changes in Patients with Sickle Cell Disease Treated with Mitapivat

Blood, 2022-11, Vol.140 (Supplement 1), p.2526-2527

2022

Volltextzugriff (PDF)

The Pyruvate Kinase Activator Mitapivat Improves Red Blood Cell Deformability and Sickling Kinetics in Adult Patients with Sickle Cell Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.2508-2509

2022

Volltextzugriff (PDF)

Quality Improvement Initiative: Improving Time to First Dose in a Sickle Cell Infusion Center

Blood, 2019-11, Vol.134 (Supplement_1), p.3404-3404

2019

Volltextzugriff (PDF)

Mitapivat (AG-348) Demonstrates Safety, Tolerability, and Improvements in Anemia, Hemolysis, Oxygen Affinity, and Hemoglobin S Polymerization Kinetics in Adults with Sickle Cell Disease: A Phase 1 Dose Escalation Study

Blood, 2021-11, Vol.138 (Supplement 1), p.10-10

2021

Volltextzugriff (PDF)

Identification of Optimal Thalassemia Screening Strategies for Migrant Populations in Thailand: A Mixed-Methods Approach

Blood, 2019-11, Vol.134 (Supplement_1), p.2112-2112

2019

Volltextzugriff (PDF)

Knowledge, Cultural, and Structural Barriers to Thalassemia Screening in Migrant Populations in Thailand

Blood, 2018-11, Vol.132 (Supplement 1), p.2228-2228

2018

Volltextzugriff (PDF)

Phase 1 Multiple Ascending Dose Study of Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Mitapivat (AG-348) in Subjects with Sickle Cell Disease

Blood, 2020-11, Vol.136 (Supplement 1), p.21-22

2020

Volltextzugriff (PDF)

Factors Related to the Progression of Sickle Cell Disease Nephropathy

Blood, 2016-12, Vol.128 (22), p.9-9

2016

Volltextzugriff (PDF)

International Multi-Site Clinical Validation of Point-of-Care Microchip Electrophoresis Test for Hemoglobin Variant Identification

Blood, 2019-11, Vol.134 (Supplement_1), p.3373-3373

2019

Volltextzugriff (PDF)

The origin of sickle cell disease in Thailand

International journal of laboratory hematology, 2019, Vol.41 (1), p.e13-e16

2019

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Englisch
(80)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Feasibility of and barriers to thalassemia screening in migrant populations: a cross-sectional study of Myanmar and Cambodian migrants in Thailand

Identification of optimal thalassemia screening strategies for migrant populations in Thailand using a qualitative approach

Fatty acid nitroalkenes – Multi-target agents for the treatment of sickle cell disease

Release of hepatic xanthine oxidase (XO) to the circulation is protective in intravascular hemolytic crisis

Pyruvate kinase activators: targeting red cell metabolism in sickle cell disease

Diagnostic Test Accuracy of Lung Ultrasound for Acute Chest Syndrome in Sickle Cell Disease: A Systematic Review and Meta-analysis

A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease

Whole genome sequence-based haplotypes reveal a single origin of the 1393 bp HBB deletion

Paper-based microchip electrophoresis for point-of-care hemoglobin testing

Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease

The origin of sickle cell disease in Thailand

Methaemoglobinaemia and haemolysis following pegloticase infusion for refractory gout in a patient with a falsely negative glucose-6-phosphate dehydrogenase deficiency result

G6PD Deficiency in an HIV Clinic Setting in the Dominican Republic

Diagnostic Test Accuracy of Lung Ultrasound for Acute Chest Syndrome in Sickle Cell Disease

Inhibition of Hypoxia Inducible Factor Prolyl Hydroxylase By FG-4592 (Roxadustat) Increases Erythropoietic Stimulation in a Mouse Model of Sickle Cell Disease

Feasibility of Near-Infrared Spectroscopy for Monitoring Hemodynamic Changes in Patients with Sickle Cell Disease Treated with Mitapivat

The Pyruvate Kinase Activator Mitapivat Improves Red Blood Cell Deformability and Sickling Kinetics in Adult Patients with Sickle Cell Disease

Quality Improvement Initiative: Improving Time to First Dose in a Sickle Cell Infusion Center

Mitapivat (AG-348) Demonstrates Safety, Tolerability, and Improvements in Anemia, Hemolysis, Oxygen Affinity, and Hemoglobin S Polymerization Kinetics in Adults with Sickle Cell Disease: A Phase 1 Dose Escalation Study

Identification of Optimal Thalassemia Screening Strategies for Migrant Populations in Thailand: A Mixed-Methods Approach

Knowledge, Cultural, and Structural Barriers to Thalassemia Screening in Migrant Populations in Thailand

Phase 1 Multiple Ascending Dose Study of Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Mitapivat (AG-348) in Subjects with Sickle Cell Disease

Factors Related to the Progression of Sickle Cell Disease Nephropathy

International Multi-Site Clinical Validation of Point-of-Care Microchip Electrophoresis Test for Hemoglobin Variant Identification

The origin of sickle cell disease in Thailand

Suchergebnisse filtern